Scalable, workflow-optimized solutions will be essential to improving cancer care in emerging and previously underserved ...
A year after his Nobel Prize win, David Baker highlights AI in protein design at Seattle's latest fundraiser to support STEM PhD students.
Despite economic uncertainty, the CEOs of life science and biotech companies are making artificial intelligence a top ...
Novo Nordisk saw a competitor’s bet and raised the stakes in metabolic dysfunction-associated steatohepatitis (MASH) with its planned up-to-$5.2 billion acquisition of Akero Therapeutics.
This week's episode features two Nobel Prize announcements, a potential gene therapy for Huntington’s, and a partnership to develop gene editing therapies for rare diseases.
The ASHG president offers some meeting highlights and what she will be looking forward to next week in Boston.
During GEN's State of Biotech virtual summit, George Church, PhD, shared his thoughts on genomics and much, much more.
Developing cardiac inflammatory organoid models incorporating multiple cell lineages is vital for novel therapies.
Researchers in China have determined to identify the genetic basis for the naked mole-rats’ increased longevity.
Programmable proteins designed with Boolean logic gates may improve targeted drug delivery precision and scalability, ...
The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results